Bacterial death and heteroresistance to antimicrobial agents;Muerte bacteriana y heterorresistencia a los antimicrobianos

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 26, Issue 8, 2008, Pages 481-484

  Martínez Martínez, Luis ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIINFECTIVE AGENT; AZTREONAM; CARBAPENEM; CEFTOBIPROLE; CLARITHROMYCIN; COLISTIN; DAPTOMYCIN; ETHAMBUTOL; FLUCONAZOLE; GLYCOPEPTIDE; METICILLIN; METRONIDAZOLE; OXACILLIN; PENICILLIN DERIVATIVE; POLYMYXIN; POLYMYXIN B; VANCOMYCIN;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL INFECTION; BACTERICIDAL ACTIVITY; BACTERIOSTASIS; CRYPTOCOCCUS NEOFORMANS; DRUG SENSITIVITY; EDITORIAL; ENTEROBACTER CLOACAE; ENTEROCOCCUS FAECIUM; EPSILOMETER TEST; ESCHERICHIA COLI; HELICOBACTER PYLORI; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIOLOGY; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; PH; PHENOTYPE; POPULATION RESEARCH; PSEUDOMONAS AERUGINOSA; QUORUM SENSING; RECURRENT DISEASE; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE;

EID: 56249121184     PISSN: 0213005X     EISSN: 15781852     Source Type: Journal    
DOI: 10.1157/13127451     Document Type: Editorial

References (36)

1. Kohanski MA, Dwyer DJ, Hayete B, Lawrence CA, Collins JJ. A common mechanism of cellular death induced by bactericidal antibiotics. Cell. 2007;130:797-810.
2. Clinical and Laboratory Standards Institute. Methods for determining bactericidal activity of antimicrobial agents; approved guideline. NCCLS document M26-A NCCLS. Wayne; 1999.
3. Piddock LJ, Walters RN. Bactericidal activities of five quinolones for Escherichia coli strains with mutations in genes encoding the SOS response or cell division. Antimicrob Agents Chemother. 1992;36:819-25.
4. Schwaber MJ, Wright SB, Carmeli Y, Venkataraman L, DeGirolami PC, Gramatikova A, et al. Clinical implications of varying degrees of vancomycin susceptibility in methicillin-resistant Staphylococcus aureus bacteremia. Emerg Infect Dis. 2003;9:657-64.
5. Rinder H. Hetero-resistance: an under-recognised confounder in diagnosis and therapy? J Med Microbiol. 2001;50:1018-20.
6. Hartman BJ, Tomasz A. Expression of methicillin resistance in heterogeneous strains of Staphylococcus aureus. Antimicrob Agents Chemother. 1986;29:85-92.
7. Ryffel C, Strässle A, Kayser FH, Berger-Bächi B. Mechanisms of hetero-resistance in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 1994;38:724-8.
8. Liu C, Chambers HF. Staphylococcus aureus with heterogeneous resistance to vancomycin: epidemiology, clinical significance, and critical assessment of diagnostic methods. Antimicrob Agents Chemother. 2003;47:3040-5.
9. Sakoulas G, Alder J, Thauvin-Eliopoulos C, Moellering RC, Eliopoulos GM. Induction of daptomycin heterogeneous susceptibility in Staphylococcus aureus by exposure to vancomycin. Antimicrob Agents Chemother. 2006;50:1581-5.
10. Nunes AP, Teixeira LM, Bastos CC, Silva MG, Ferreira RB, Fonseca LS, Santos KR. Heterogeneous resistance to vancomycin in Staphylococcus epidermidis, Staphylococcus haemolyticus and Staphylococcus warneri clinical strains: characterisation of glycopeptide susceptibility profiles and cell wall thickening. Int J Antimicrob Agents. 2006;27:307-15.
11. Alam MR, Donabedian S, Brown W, Gordon J, Chow JW, Zervos MJ, Hershberger E. Heteroresistance to vancomycin in Enterococcus faecium. J Clin Microbiol. 2001;39:3379-81.
12. Morand B, Muhlemann K. Heteroresistance to penicillin in Streptococcus pneumonia. Proc Natl Acad Sci USA. 2007;104:14098-103.
13. Pascual A, Martínez-Martínez L, Clavijo MJ, García-Perea MD, Perea EJ. Comparison of three methods of determining the in-vitro susceptibilities of Acinetobacter baumannii isolates to imipenem. J Antimicrob Chemother. 1997;40:742-3.
14. Pournaras S, Ikonomidis A, Markogiannakis A, Maniatis AN, Tsakris A. Heteroresistence to carbapenems in Acinetobacter baumannii. J Antimicrob Chemother. 2005;55:1055-6.
15. Li J, Rayner CR, Nation RL, Owen RJ, Spelman D, Tan KE, Liolios L. Hetero-resistance to colistin in multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother. 2006;50:2946-50.
16. Tan CH, Li J, Nation RL. Activity of colistin against heteroresistant Acinetobacter baumannii and emergence of resistance in an in vitro pharmacokinetic/pharmcodynamic model. Antimicrob Agents Chemother. 2007;51:3413-5.
17. Matteo MJ, Pérez CV, Domingo MR, Olmos M, Sánchez C, Catalano M. DNA sequence analysis of rdxA and frxA from paired metronidazole-sensitive and -resistant Helicobacter pylori isolates obtained from patients with heteroresistance. Int J Antimicrob Agents. 2006;27:152-8.
18. Kim JJ, Kim JG, Kwon DH. Mixed-infection of antibiotic susceptible and resistant Helicobacter pylori isolates in a single patient and underestimation of antimicrobial susceptibility testing. Helicobacter. 2003;3:202-6.
19. Rinder H, Mieskes KT, Löscher T. Heteroresistance in Mycobacterium tuberculosis. Int J Tuberc Lung Dis. 2001;5:339-45.
20. Yamazumi T, Pfaller MA, Messer SA, Houston AK, Boyken L, Hollis RJ, et al. Characterization of heteroresistance to fluconazole among clinical isolates of Cryptococcus neoformans. J Clin Microbiol. 2003;41:267-72.
21. Wootton X, Howe RA, Hillman R, Walsh TR, Bennet PM, MacGowan AP. A modified population analysis method (PAP) to detect heteroresistance to vancomycin in Staphylococcus aureus in UK hospital. J Antimicrob Chemother. 2001;47:399-403.
22. Fernández-Cuenca F, Egea P, López Cerero L, Díaz-De Alba P, Vila J, Pascual A. Comparación de tres métodos para determinar la sensibilidad a imipenem y meropenem en Acinetobacter baumannii con fenotipo heterorresistente a carbapenemes. Enferm Infecc Microbiol Clin. 2008;26:485-8.
23. Sutherland R, Rolinson GN. Characteristics of methicillin-resistant staphylococci. J Bacteriol. 1964;87:887-99.
24. Aritaka N, Hanaki H, Cui L, Hiramatsu K. Combination effect of vancomycin and beta-lactams against a Staphylococcus aureus strain, Mu3, with heterogeneous resistance to vancomycin. Antimicrob Agents Chemother. 2001;45:1292-4.
25. Lo-Ten-Foe JR, De Smet AM, Diederen BM, Kluytmans JA, Van Keulen PH. Comparative evaluation of the VITEK 2, disk diffusion, etest, broth microdilution, and agar dilution susceptibility testing methods for colistin in clinical isolates, including heteroresistant Enterobacter cloacae and Acinetobacter baumannii strains. Antimicrob Agents Chemother. 2007;51:3726-30.
26. Juan C, Moyá B, Pérez JL, Oliver A. Stepwise upregulation of the Pseudomonas aeruginosa chromosomal cephalosporinase conferring high-level beta-lactam resistance involves three AmpD homologues. Antimicrob Agents Chemother. 2006;50:1780-7.
27. Drlica K, Zhao X. Mutant selection window hypothesis updated. Clin Infect Dis. 2007;44:681-8.
28. Hawley JS, Murray CK, Jorgensen JH. Colistin heteroresistance in Acinetobacter and its association with previous colistin therapy. Antimicrob Agents Chemother. 2008;52:351-2.
29. Moyed HS, Bertrand KP. hipA, a newly recognized gene of Escherichia coli K-12 that affects frequency of persistence after inhibition of murein synthesis. J Bacteriol. 1983;155:768-75.
30. Wolfson JS, Hooper DC, McHugh GL, Bozza MA, Swartz MN. Mutants of Escherichia coli K-12 exhibiting reduced killing by both quinolone and beta-lactam antimicrobial agents. Antimicrob Agents Chemother. 1990;34:1938-43.
31. Buts L, Lah J, Dao-Thi MH, Wyns L, Loris R. Toxin-antitoxin modules as bacterial metabolic stress managers. Trends Biochem Sci. 2005;30:672-9.
32. Braeken K, Moris M, Daniels R, Vanderleyden J, Michiels J. New horizons for (p)ppGpp in bacterial and plant physiology. Trends Microbiol. 2006;14:45-54.
33. González JE, Keshavan ND. Messing with bacterial quorum sensing. Microbiol Mol Biol Rev. 2006;70:859-75.
34. Fernández F, Gómez M, Egea P, Vila J, Pascual A. Asociación entre heterorresistencia a carbapenemes en acinetobacter baumannii, producción de beta-lactamasas (Ampc y oxacilinasas) y secuencias de inserción tipo ISA-ba. Resúmenes del XIII Congreso de la Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica (SEIMC), 2008, No. 12, p. 6.
35. Neoh HM, Cui L, Yuzawa H, Takeuchi F, Matsuo M, Hiramatsu K. Mutated response regulator graR is responsible for phenotypic conversion of Staphylococcus aureus from heterogeneous vancomycin-intermediate resistance to vancomycin-intermediate resistance. Antimicrob Agents Chemother. 2008;52:45-53.
36. Sakoulas G, Eliopoulos GM, Moellering RC Jr, Wennersten C, Venkataraman L, Novick RP, Gold HS. Accessory gene regulator (agr) locus in geographically diverse Staphylococcus aureus isolates with reduced susceptibility to vancomycin. Antimicrob Agents Chemother. 2002;46:1492-502.